http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d136d142dde855f876d5f37ee6b77557
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Merlo |
| name | Anna Merlo |
| given-name | Anna |
| organization-name | Unit of Microbiology and Virology, Department of Laboratory Medicine Maggiore della Carità Hospital Novara Italy Department of Immunology and Blood Transfusions, San Bortolo Hospital, Vicenza, Italy Servicio de Otorrinolaringología (A.M., S.B.d.Q., P.S., I.Z., C.S., M.-D.C.), Asturias, Spain; Instituto Universitario de Oncologia del Principado de Asturias (A.M., S.B.d.Q., P.S., I.Z., M.B., A.A., C.S., M.-D.C.), Universidad de Oviedo, Asturias, Spain Otorhinolaryngology Service, Hospital Universitario Central de Asturias, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo, CIBERONC, Oviedo, Spain Authors' Affiliations: 1Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Génétique; 2Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine; 3INSERM, UMR970, Paris Cardiovascular Research Center; 4Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Médecine vasculaire et d'Hypertension artérielle; 5INSERM U1016, CNRS UMR 8104, Institut Cochin; 6Assistance Publique Hôpitaux de Paris, Hôpital de Bicêtre Endocrinology Unit, Le Kremlin-Bicêtre; 7Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Unité de Prévention Cardiovasculaire, Pôle Endocrinologie, Paris, France; 8Hereditary Endocrine Cancer Group, 9Monoclonal Antibodies Unit, 10Human Genetics Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid; 11Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Spain; 12Familial Cancer Clinic and Oncoendocrinology, Veneto Institute of Oncology, IRCCS; 13Department of Medical School of Medicine and Surgery, University of Milan-Bicocca, 20126 Milan, Italy University of Milan-Bicocca, Milan, Italy Department of Oncology and Surgical Sciences, University of Padova, Via F. Gallini 2, 35128 Padova, Italy *Veneto Institute of Oncology, 35128 Padua, Italy; Veneto Institute of Oncology IOV - IRCCS, Padua, Italy 1Department of Oncology and Surgical Sciences, University of Padova and 2Istituto Oncologico Veneto-IRCCS, Padova, Italy; 3Department of Gene Therapy, Imperial College, London, United Kingdom; 4San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy; and 5Laboratory of Experimental Tumor Immunology, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, the Netherlands Authors' Affiliations: 1Cancer Bio-Immunotherapy Unit, 2Clinical and Experimental Pharmacology, 3Medical Oncology A, 4Experimental Oncology 1, 5Laboratory Medicine, and 6Pathology, C.R.O., IRCCS–National Cancer Institute, Aviano; 7Department of Oncology and Surgical Sciences, University of Padova/IOV, Padova; 8Areta International, Gerenzano; and 9Human Tumors Immunobiology Unit, Fondazione IRCCS - INT, Milan, Italy *Department of Oncology and Surgical Sciences and Servicio de Otorrinolaringología, Hospital Universitario Central de Asturias, Instituto Universitario de Oncología del Principado de Asturias, Universidad de Oviedo Oviedo Spain |
Incoming Links
Total number of triples: 48.